A Study of the Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults

Clinical trial NCT02676895 · COMPLETED

Trial details

NCT number: NCT02676895
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Shigella Sonnei Infection

Start date: 2016-08-08
Primary completion: 2017-03-10
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.